Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
At the ASH 2021 annual meeting in Atlanta, Georgia, new clinical data were reported in the settings of acute myeloid leukemia (AML), chronic myeloid leukemia (CML), and acute lymphoblastic leukemia (ALL). In this expert analysis module, B. Douglas Smith, MD, and Eunice S. Wang, MD, review and discuss the clinical implications of key findings for these diseases that were presented at the meeting.
Please note that the slide thumbnails embedded in this activity link to short PowerPoint slidesets, each focused on the specific study of interest. The slides for the studies covered in this activity may be downloaded by clicking on any of the thumbnails within the activity.
Clinical Care Options plans to measure the educational impact of this activity. Several questions will be asked twice: once at the beginning of the activity and then once again after the discussion that informs the best choice. Your responses will be aggregated for analysis, and your specific responses will not be shared.
Before we begin this educational activity, please take a moment to answer the following questions.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.